Median aperture
Median aperture (also known as the median aperture of the fourth ventricle, foramen of Magendie, or Magendie's foramen) is an opening in the brain that allows the passage of cerebrospinal fluid (CSF) from the fourth ventricle to the subarachnoid space. It is one of the three openings in the ventricles, the other two being the lateral apertures (also known as the foramina of Luschka).
Etymology[edit | edit source]
The median aperture is named after the French physician François Magendie who discovered it. The term "aperture" comes from the Latin "apertura", meaning an opening, while "median" refers to its central location.
Anatomy[edit | edit source]
The median aperture is located in the inferior part of the fourth ventricle, in the rhomboid fossa. It is the only median opening, with one located in each of the ventricles. The median aperture allows the cerebrospinal fluid (CSF) to flow from the fourth ventricle into the cisterna magna, and then into the subarachnoid space surrounding the brain and spinal cord.
Function[edit | edit source]
The primary function of the median aperture is to allow the passage of CSF from the fourth ventricle to the subarachnoid space. This is crucial for the circulation of CSF, which provides cushioning for the brain, helps to deliver nutrients to the brain and remove waste, and plays a role in maintaining the internal environment of the brain.
Clinical significance[edit | edit source]
Blockage or obstruction of the median aperture can lead to a condition known as hydrocephalus, where there is an accumulation of CSF in the brain. This can cause increased intracranial pressure and can lead to symptoms such as headache, nausea, vomiting, and in severe cases, can be life-threatening.
See also[edit | edit source]
References[edit | edit source]
Median aperture Resources | ||
---|---|---|
|
|
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD